Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells

URN to cite this document:

urn:nbn:de:bvb:355-epub-204694 Copy

DOI to cite this document:

10.5283/epub.20469 Copy

Jilg, W. ; Voltz, R. ; Markert-Hahn, C. ; Mairhofer, H. ; Münz, I. ; Wolf, Hans J.

Preview

PDF (1MB)

Date of publication of this fulltext: 13 Apr 2011 09:09

---

Alternative links to fulltext:Pubmed

---

Details

Item type:	Article
Journal or Publication Title:	Cancer research
Publisher:	American Association for Cancer Research : AACR
Volume:	51
Number of Issue or Book Chapter:	1
Page Range:	pp. 27-32
Date:	1991
Institutions:	Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Identification Number:	Value Type 1899042 PubMed ID
Classification:	Notation Type Blotting, Northern MESH Burkitt Lymphoma/immunology MESH Cell Line MESH Cell Transformation, Viral MESH Electrophoresis, Gel, Two-Dimensional MESH Histocompatibility Antigens Class I/metabolism MESH Humans MESH Interferon-gamma/pharmacology MESH Lymphocytes/microbiology MESH Major Histocompatibility Complex MESH Molecular Weight MESH Pokeweed Mitogens/pharmacology MESH Precipitin Tests MESH RNA, Messenger/genetics MESH Tumor Virus Infections/immunology MESH
Dewey Decimal Classification:	600 Technology > 610 Medical sciences Medicine
Status:	Published
Refereed:	Unknown
Created at the University of Regensburg:	Unknown
Item ID:	20469

Preview

Export bibliographical data

ASCII CitationAtomBibTeXData Cite XMLDataCite XML OAIDublin CoreEndNoteHTML CitationJSON LDMETSMODSOpenAPCRDF+N-TriplesRDF+N3RDF+XMLReferReference ManagerSimple MetadataXMLxMetaDissPlus

---

Abstract

Epstein-Barr virus (EBV) carrying lymphoblastoid cell lines (LCLs) and EBV-positive Burkitt lymphoma (BL) cells were compared for their expression of class I antigens of the major histocompatibility complex. Five common BL lines, LCLs, pokeweed mitogen-stimulated blasts and resting B-cells from healthy donors, and eight pairs of BL cells and LCLs, each pair originating from one patient, were ...

Abstract

Epstein-Barr virus (EBV) carrying lymphoblastoid cell lines (LCLs) and EBV-positive Burkitt lymphoma (BL) cells were compared for their expression of class I antigens of the major histocompatibility complex. Five common BL lines, LCLs, pokeweed mitogen-stimulated blasts and resting B-cells from healthy donors, and eight pairs of BL cells and LCLs, each pair originating from one patient, were tested. Quantitative analysis was performed using a radioimmunoassay; qualitative aspects were studied by one- and two-dimensional gel electrophoresis. In general, LCLs expressed significantly higher amounts of class I antigens than BL cells, the latter showing class I densities similar to or lower than peripheral resting B-cells. From analysis of the expression of class I-specific RNA, there is some evidence that class I antigen expression is regulated on the transcriptional level. In two BL cells studied, class I expression could be enhanced by gamma-interferon, whereas the corresponding LCLs seemed to be refractory to this treatment. One- and two-dimensional gel electrophoresis showed that in some BL lines, in addition to the generally lower class I expression, distinct class I specificities were down-regulated. None of these alterations in class I expression was EBV specific; however, they may well play a role in the recognition of BL cells and LCLs by cellular immune mechanisms. Thus, down-regulation of class I antigens may contribute to the resistance of BL cells to cytotoxic T-lymphocytes, whereas their enhanced expression may improve the recognition of EBV-infected LCLs.

---

---

Metadata last modified: 26 Nov 2020 07:03

Owner only: item control page

Download Statistics

Download Statistics

Download Statistics

Download Statistics

Downloads

Downloads per month over past year

Altmetric

Altmetric

Altmetric

Alternative Statistics (altmetrics)

More literature (via CORE)

More literature (via CORE)

More literature (via CORE)

More literature (via CORE)